These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 18848826

  • 1. Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.
    Katsuda S, Kawashiri MA, Inazu A, Tada H, Tsuchida M, Kaneko Y, Nozue T, Nohara A, Okada T, Kobayashi J, Michishita I, Mabuchi H, Yamagishi M.
    Clin Chim Acta; 2009 Jan; 399(1-2):64-8. PubMed ID: 18848826
    [Abstract] [Full Text] [Related]

  • 2. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
    Whitfield AJ, Marais AD, Robertson K, Barrett PH, van Bockxmeer FM, Burnett JR.
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872264
    [Abstract] [Full Text] [Related]

  • 3. Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia.
    Elias N, Patterson BW, Schonfeld G.
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2714-21. PubMed ID: 10559016
    [Abstract] [Full Text] [Related]

  • 4. Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations.
    Di Leo E, Magnolo L, Bertolotti M, Bourbon M, Carmo Pereira S, Pirisi M, Calandra S, Tarugi P.
    Clin Genet; 2008 Sep; 74(3):267-73. PubMed ID: 18492086
    [Abstract] [Full Text] [Related]

  • 5. Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21.
    Yue P, Tanoli T, Wilhelm O, Patterson B, Yablonskiy D, Schonfeld G.
    Metabolism; 2005 May; 54(5):682-8. PubMed ID: 15877300
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.
    Tanoli T, Yue P, Yablonskiy D, Schonfeld G.
    J Lipid Res; 2004 May; 45(5):941-7. PubMed ID: 14967820
    [Abstract] [Full Text] [Related]

  • 8. Familial hypobetalipoproteinemia in a hospital survey: genetics, metabolism and non-alcoholic fatty liver disease.
    Gutiérrez-Cirlos C, Ordóñez-Sánchez ML, Tusié-Luna MT, Patterson BW, Schonfeld G, Aguilar-Salinas CA.
    Ann Hepatol; 2011 May; 10(2):155-64. PubMed ID: 21502677
    [Abstract] [Full Text] [Related]

  • 9. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides.
    Chen Z, Fitzgerald RL, Averna MR, Schonfeld G.
    J Biol Chem; 2000 Oct 20; 275(42):32807-15. PubMed ID: 10893242
    [Abstract] [Full Text] [Related]

  • 10. Homozygous familial hypobetalipoproteinemia. Increased LDL catabolism in hypobetalipoproteinemia due to a truncated apolipoprotein B species, apo B-87Padova.
    Gabelli C, Bilato C, Martini S, Tennyson GE, Zech LA, Corsini A, Albanese M, Brewer HB, Crepaldi G, Baggio G.
    Arterioscler Thromb Vasc Biol; 1996 Sep 20; 16(9):1189-96. PubMed ID: 8792774
    [Abstract] [Full Text] [Related]

  • 11. Genetic variants of ApoE account for variability of plasma low-density lipoprotein and apolipoprotein B levels in FHBL.
    Yue P, Isley WL, Harris WS, Rosipal S, Akin CD, Schonfeld G.
    Atherosclerosis; 2005 Jan 20; 178(1):107-13. PubMed ID: 15585207
    [Abstract] [Full Text] [Related]

  • 12. Pediatric gallstone disease in familial hypobetalipoproteinemia.
    Lancellotti S, Zaffanello M, Di Leo E, Costa L, Lonardo A, Tarugi P.
    J Hepatol; 2005 Jul 20; 43(1):188-91. PubMed ID: 15894400
    [Abstract] [Full Text] [Related]

  • 13. Homozygous familial hypobetalipoproteinemia: two novel mutations in the splicing sites of apolipoprotein B gene and review of the literature.
    Cefalù AB, Norata GD, Ghiglioni DG, Noto D, Uboldi P, Garlaschelli K, Baragetti A, Spina R, Valenti V, Pederiva C, Riva E, Terracciano L, Zoja A, Grigore L, Averna MR, Catapano AL.
    Atherosclerosis; 2015 Mar 20; 239(1):209-17. PubMed ID: 25618028
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
    Hooper AJ, Heeks L, Robertson K, Champain D, Hua J, Song S, Parhofer KG, Barrett PH, van Bockxmeer FM, Burnett JR.
    J Clin Endocrinol Metab; 2015 Nov 20; 100(11):E1484-90. PubMed ID: 26323024
    [Abstract] [Full Text] [Related]

  • 15. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.
    Schonfeld G, Patterson BW, Yablonskiy DA, Tanoli TS, Averna M, Elias N, Yue P, Ackerman J.
    J Lipid Res; 2003 Mar 20; 44(3):470-8. PubMed ID: 12562873
    [Abstract] [Full Text] [Related]

  • 16. Apoprotein B-100 production is decreased in subjects heterozygous for truncations of apoprotein B.
    Aguilar-Salinas CA, Barrett PH, Parhofer KG, Young SG, Tessereau D, Bateman J, Quinn C, Schonfeld G.
    Arterioscler Thromb Vasc Biol; 1995 Jan 20; 15(1):71-80. PubMed ID: 7749818
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. APOB CRISPR-Cas9 Engineering in Hypobetalipoproteinemia: A Promising Tool for Functional Studies of Novel Variants.
    Vanhoye X, Janin A, Caillaud A, Rimbert A, Venet F, Gossez M, Dijk W, Marmontel O, Nony S, Chatelain C, Durand C, Lindenbaum P, Rieusset J, Cariou B, Moulin P, Di Filippo M.
    Int J Mol Sci; 2022 Apr 13; 23(8):. PubMed ID: 35457099
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular diagnosis of hypobetalipoproteinemia: an ENID review.
    Tarugi P, Averna M, Di Leo E, Cefalù AB, Noto D, Magnolo L, Cattin L, Bertolini S, Calandra S.
    Atherosclerosis; 2007 Dec 13; 195(2):e19-27. PubMed ID: 17570373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.